• Solanesol: Technical Guidance for Polyisoprenoid Alcohol Res

  2026-07-22

  Solanesol is a high-purity polyisoprenoid alcohol designed for biochemical research involving hydrophobic compound workflows, such as apoptosis and metabolic enzyme studies. It is not suitable for aqueous or ethanol-based systems and should not be used for diagnostic or medical purposes.

• Engage & Evasion Strategy Enhances EV Therapy for Ischemia

  2026-07-22

  Liu et al. introduce a dual 'Engage & Evasion' approach to improve extracellular vesicle (EV) therapy for ischemic diseases by reducing rapid clearance via the mononuclear phagocyte system (MPS). Their method leverages sequential administration of CD47-low and CD47-high EVs to optimize systemic distribution and therapeutic efficacy.

• Pepstatin A: Precision Aspartic Protease Inhibitor Workflows

  2026-07-21

  Pepstatin A, from APExBIO, sets the benchmark for aspartic protease inhibition in advanced assays—enabling precise dissection of viral, lysosomal, and bone metabolism pathways. This guide translates recent mechanistic insights and peer-reviewed protocols into actionable workflows for robust, reproducible results.

• 5-(N,N-dimethyl)-Amiloride Hydrochloride in Endothelial Inju

  2026-07-21

  5-(N,N-dimethyl)-Amiloride hydrochloride stands out for its selective Na+/H+ exchanger inhibition, enabling precise dissection of intracellular pH regulation and ion transport in endothelial and cardiac research. This guide presents advanced workflows, troubleshooting, and translational insights—anchored in recent biomarker discoveries for sepsis and vascular dysfunction.

• LY2886721 (A8465): Reliable BACE1 Inhibition for Alzheimer’s

  2026-07-20

  This article delivers a scenario-driven, evidence-based overview of LY2886721 (SKU A8465), a potent BACE inhibitor for Alzheimer’s disease research. We explore its nanomolar efficacy, best-practice integration in cell and animal assays, and practical vendor selection, demonstrating its value for reproducibility and data integrity in amyloid beta reduction workflows.

• METTL17 Regulates Ferroptosis via Mitochondrial Translation

  2026-07-20

  This study demonstrates that the mitochondrial protein METTL17 modulates sensitivity to ferroptosis and tumorigenesis in colorectal cancer (CRC) by controlling mitochondrial RNA methylation and translation. The findings reveal a critical mitochondrial defense mechanism against ferroptosis and position METTL17 as a potential target for CRC therapy.

• PEG-Lipid Selection Dominates LNP-mRNA Delivery Efficiency I

  2026-07-19

  This study systematically dissects how the type of PEG-lipid in lipid nanoparticle (LNP) formulations critically determines mRNA delivery efficacy across in vitro and in vivo settings. The findings emphasize that even minor PEG-lipid variations substantially influence LNP potency, guiding rational design for mRNA therapeutics and reporter assays.

• n-Dodecyl-β-D-maltoside: Precision Detergent for Integrin Re

  2026-07-18

  Explore how n-Dodecyl-β-D-maltoside (DDM) empowers advanced integrin structural biology, bridging next-generation cryo-EM findings to practical membrane protein assay optimization. Discover distinct protocol insights and expert guidance for challenging membrane protein targets.

• Strategic Protease Inhibition: Driving Translational Advance

  2026-07-17

  This article explores the mechanistic and strategic imperatives of protease inhibition for translational researchers. By integrating recent advances in cancer stem cell metabolomics and referencing the APExBIO Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO), we present a forward-looking guide to optimizing protein integrity in sensitive workflows. The discussion bridges mechanistic insight, protocol guidance, and the evolving landscape of translational proteomics.

• Bardoxolone methyl (A3221): Data-Driven Solutions in Cell As

  2026-07-17

  This article provides an evidence-based, scenario-driven roadmap for leveraging Bardoxolone methyl (SKU A3221) in cell viability, proliferation, and cytotoxicity workflows. Addressing real-world lab challenges such as redox pathway reproducibility, pathway specificity, and vendor reliability, it synthesizes recent mechanistic advances and quantitative performance data to guide biomedical researchers toward robust, interpretable results.

• Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO): Use G

  2026-07-16

  The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) prevents unwanted protein degradation during extraction and analysis, particularly in workflows where preservation of divalent cations is necessary. This solution is well-suited for Western blotting, co-immunoprecipitation, and kinase/phosphorylation analysis, but should not be used when metalloprotease inhibition via EDTA is required.

• EdU Flow Cytometry Assay Kits (Cy5): Precision S-Phase Detec

  2026-07-16

  The EdU Flow Cytometry Assay Kits (Cy5) deliver robust, multiplex-ready cell proliferation analysis using advanced click chemistry and Cy5 fluorescence. Learn how to optimize workflows for S-phase detection, streamline multiplexing, and troubleshoot common pitfalls—enabling confident cell cycle and biomarker research across cancer, pharmacodynamics, and wound healing.

• Melatonin Shields Testicular Mitochondria from BPA-Induced S

  2026-07-15

  This study demonstrates that melatonin mitigates Bisphenol A (BPA)-induced oxidative damage in mouse testicular tissue by preserving mitochondrial function and reducing apoptosis. The findings reveal new mechanistic insights into how melatonin counteracts endocrine disruptor toxicity, with translational potential for reproductive health research.

• 3-Dehydroteasterone Derivatives: Synthesis and Bioactivity I

  2026-07-15

  This study introduces novel 3-dehydroteasterone (3-DT) derivatives with 23,24-dinorcholanic side chains and benzoate groups at C-22, evaluating their growth-regulating activity against standard brassinosteroids using plant bioassays. Key findings clarify structure–activity relationships and provide a benchmark for future synthesis of potent plant growth regulators.

• WY-14643 (Pirinixic Acid): PPARα Agonism in Hepatic Pyroptos

  2026-07-14

  Explore how WY-14643 (Pirinixic Acid) advances metabolic and anti-inflammatory research by targeting PPARα-driven pyroptosis in liver injury. This article delivers a rigorous, practical guide for leveraging WY-14643 in preclinical models, with unique insight into its role in regulating hepatocyte cell death.

16630 records 1/1109 page Next 12345 下5页 Last page